These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16949492)

  • 21. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Am J Cardiol; 2006 Sep; 98(5A):25J-33J. PubMed ID: 16931203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
    Dargie HJ; Hildebrandt PR; Riegger GA; McMurray JJ; McMorn SO; Roberts JN; Zambanini A; Wilding JP
    J Am Coll Cardiol; 2007 Apr; 49(16):1696-704. PubMed ID: 17448371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of combination therapy with preduktal and prestarium on the left ventricular function in the postinfarction period].
    Dzhindzholiia NR; Megreladze II
    Georgian Med News; 2008 Feb; (155):20-3. PubMed ID: 18401050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
    Rosano GM; Vitale C; Sposato B; Mercuro G; Fini M
    Cardiovasc Diabetol; 2003 Nov; 2():16. PubMed ID: 14641923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Left ventricular systolic function, paced QT dispersion, exercise tolerance and quality of life in long term follow up after ventricular pacemaker implantation (VVIR) and radiofrequency atrioventricular junction ablation in drug refractory atrial fibrillation].
    Lelakowski J; Małecka B; Bednarek J; Bigaj J
    Pol Merkur Lekarski; 2008 Mar; 24(141):190-4. PubMed ID: 18634282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical left ventricular remodeling leads to better long-term survival and exercise tolerance than coronary artery bypass grafting alone in patients with moderate ischemic cardiomyopathy.
    Dzemali O; Risteski P; Bakhtiary F; Singer E; Zierer A; Kleine P; Moritz A
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):663-8. PubMed ID: 19698853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waltz dancing in patients with chronic heart failure: new form of exercise training.
    Belardinelli R; Lacalaprice F; Ventrella C; Volpe L; Faccenda E
    Circ Heart Fail; 2008 Jul; 1(2):107-14. PubMed ID: 19808280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term oral administration of dipyridamole improves both cardiac and physical status in patients with mild to moderate chronic heart failure: a prospective open-randomized study.
    Sanada S; Asanuma H; Koretsune Y; Watanabe K; Nanto S; Awata N; Hoki N; Fukunami M; Kitakaze M; Hori M
    Hypertens Res; 2007 Oct; 30(10):913-9. PubMed ID: 18049022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
    Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of trimetazidine in management of ischemic cardiomyopathy.
    Bertomeu-Gonzalez V; Bouzas-Mosquera A; Kaski JC
    Am J Cardiol; 2006 Sep; 98(5A):19J-24J. PubMed ID: 16931202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.
    Bové T; Van Belleghem Y; Vandenplas G; Caes F; François K; De Backer J; De Pauw M; Van Nooten G
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):995-1003; discussion 1003. PubMed ID: 19136274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.